AKT1 and kidney cancer: Huang and Zhang [49] identified FDFT1 as a potential biomarker associated with ferroptosis in kidney cancer (KIRC), finding that FDFT1 upregulation inhibited cell proliferation, migration, and invasion, with potential antitumor effects occurring via the AKT signaling pathway.